PharmaShots Weekly Snapshots (September 06 -10, 2021)

 PharmaShots Weekly Snapshots (September 06 -10, 2021)

PharmaShots Weekly Snapshots (September 06 -10, 2021)

Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration

Published: Sept 10, 2021 | Tags: Boehringer Ingelheim, Twist, Therapeutic Antibodies, Multiple Targets

Samsung Bioepis Reports Results of Post-Hoc Analysis from P-III Study of Byooviz (biosimilar, ranibizumab) for the Treatment of nAMD

Published: Sept 10, 2021 | Tags: Samsung Bioepis, Post-Hoc Analysis, P-III, Study, Byooviz, biosimilar, ranibizumab, nAMD

Boehringer Ingelheim and Eli Lilly’s Jardiance (empagliflozin) Receive the US FDA’s Breakthrough Therapy Designation for the Treatment of Heart Failure with Preserved Ejection Fraction

Published: Sept 10, 2021 | Tags: Boehringer Ingelheim, Eli Lilly, Jardiance, empagliflozin, Breakthrough Therapy Designation, Heart Failure, Preserved Ejection Fraction, US

Dermavant Reports the First Patient Dosing in P-III ADORING Program of Tapinarof for the Treatment of Atopic Dermatitis

Published: Sept 10, 2021 | Tags: Dermavant, P-III, ADORING Program, Tapinarof, Atopic Dermatitis

Roche to Acquire TIB Molbiol for Bolstering its Molecular Diagnostics Portfolio

Published: Sept 10, 2021 | Tags: Roche, TIB Molbiol, PCR-Test Portfolio, Infectious Diseases

Eli Lilly Signs a License and Research Agreement with ProQR to Develop & Commercialize RNA Therapeutic for the Treatment of Liver and Nervous System Disorders

Published: Sept 10, 2021 | Tags: Eli Lilly, ProQR, RNA Therapeutic, Liver, Nervous System

ICU Medical Commits to Acquire Smith for ~$2.35B

Published: Sept 9, 2021 | Tags:  ICU Medical, Acquire, Smith, ~$2.35B

Cardiff Oncology Reports Results of Onvansertib in P-Ib/II Trial for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer

Published: Sept 9, 2021 | Tags: Cardiff Oncology, Onvansertib, , KRAS-Mutated Metastatic Colorectal Cancer

AstraZeneca Reports Results of PT027 (albuterol and budesonide) in P-III MANDALA and DENALI Trials for the Treatment of Asthma

Published: Sept 9, 2021 | Tags: AstraZeneca, PT027, albuterol, budesonide, P-III, MANDALA, DENALI Trials, Asthma

Sanofi Provides Update on P-III PEGASUS Trial of Rilzabrutinib for the Treatment of Pemphigus

Published: Sept 9, 2021 | Tags: Sanofi, P-III, PEGASUS Trial, Rilzabrutinib, Pemphigus

AstraZeneca and Hutchmed Initiate P-III SANOVO Trial for Orpathys (savolitinib) + Tagrisso (osimertinib) as a 1L Therapy for Non-small Cell Lung Cancer in China

Published: Sept 9, 2021 | Tags: AstraZeneca, Hutchmed, P-III, SANOVO Trial, Orpathys, savolitinib, Tagrisso, Osimertinib, Non-small Cell Lung Cancer, China

Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706, a Proposed Biosimilar Avastin (bevacizumab)

Published: Sept 9, 2021 | Tags: Bio-Thera, Sandoz, BAT1706, Avastin, bevacizumab

AstraZeneca Presents Results of Fasenra in P-IIIb PONENTE Study for the Treatment of Asthma at ERS 2021

Published: Sept 8, 2021 | Tags: AstraZeneca, Fasenra, P-IIIb, PONENTE Study, Severe Asthma, ERS 2021

United Therapeutics Presents Results of Tyvaso DPI in BREEZE Clinical Study for the Treatment of Pulmonary Arterial Hypertension at ERS 2021

Published: Sept 8, 2021 | Tags: United Therapeutics, Tyvaso DPI, BREEZE Clinical Study, Pulmonary Arterial Hypertension, ERS 2021

AM-Pharma Enters into an Exclusive License Agreement with Kyowa Kirin to Commercialize Ilofotase Alfa in Japan

Published: Sept 8, 2021 | Tags: AM-Pharma, Kyowa Kirin, Commercialize, Ilofotase Alfa, Japan

Google Collaborates with Mayo Clinic to Develop AI Algorithm for the Treatment of Neurological Diseases

Published: Sept 8, 2021 | Tags: Mayo Clinic, Google, AI Algorithm, Brain Stimulation Devices

Sanofi to Acquire Kadmon for ~$1.9B

Published: Sept 8, 2021 | Tags: Sanofi, Acquire, Kadmon, ~$1.9B

Genentech Signs a License Agreement with Adaptimmune to Develop and Commercialize Cancer-Targeted Allogeneic T-cell Therapies

Published: Sept 8, 2021 | Tags: Genentech, Adaptimmune, Cancer-Targeted, Allogeneic T-cell Therapies

Hetero’s Tocira (biosimilar, tocilizumab) Receives the DCGI’s EUA for the Treatment of COVID-19 in Hospitalized Adults

Published: Sept 7, 2021 | Tags: Hetero, Actemra, biosimilar, tocilizumab, DCGI, EUA, COVID-19

Sorrento Initiates Enrollment in P-II MSC-COV-202BR Study for the Treatment of Acute Respiratory Distress due to COVID-19 in Brazil

Published: Sept 7, 2021 | Tags: Sorrento, P-II, MSC-COV-202BR Study, COVID-19, Acute Respiratory Distress, Brazil

Impel NeuroPharma’s Trudhesa (dihydroergotamine mesylate) Nasal Spray Receives the US FDA’s Approval for the Treatment of Migraine

Published: Sept 7, 2021 | Tags: Impel NeuroPharma, Trudhesa, dihydroergotamine mesylate, Nasal Spray, US, FDA, Approval, Migraine

Advent and GIC to Acquire Sobi for ~$8B

Published: Sept 7, 2021 | Tags: Advent, GIC, Acquire, Sobi, ~$8B

NeuExcell Signs a Research Agreement with Spark to Develop a Novel Gene Therapy for Huntington’s Disease

Published: Sept 7, 2021 | Tags: NeuExcell, Spark, Novel Gene Therapy, Huntington’s Disease

JW’s Relmacabtagene Autoleucel Receives the NMPA’s Approval for the Treatment of R/R Large B-Cell Lymphoma in China

Published: Sept 7, 2021 | Tags: JW, Relmacabtagene Autoleucel, NMPA, Approval, R/R Large B-Cell Lymphoma, China

Moderna’s Spikevax Receives TGA’s Provisional Approval to Treat COVID-19 in Patients Aged 12-17 Years

Published: Sept 6, 2021 | Tags: Moderna, Spikevax, TGA, Provisional Approval, COVID-19

AstraZeneca and Amgen’s Tezepelumab Demonstrates 86% Reduction in Exacerbations in Patients with Asthma and Nasal Polyps

Published: Sept 6, 2021 | Tags: AstraZeneca, Amgen, Tezepelumab, Asthma, Nasal Polyps

Bayer Reports Results of Eliapixant in P-IIb PAGANINI Study for Patients with Refractory Chronic Cough

Published: Sept 6, 2021 | Tags: Bayer, Eliapixant, P-IIb, PAGANINI Study, Refractory Chronic Cough

BioMarin Reports FDA’s Hold on P-I/II Phearless Trial of BMN 307 in Adults with PKU

Published: Sept 6, 2021 | Tags: BioMarin, FDA, P-I/II, Phearless Trial, BMN 307, PKU

Dr. Reddy’s Collaborates with Citius to Sell Rights of its Anti-Cancer Agent (E7777)

Published: Sept 6, 2021 | Tags: Dr. Reddy, Citius, Anti-Cancer Agent, E7777

Novartis to Discontinue CIRRUS-1 Study of CFZ533 (iscalimab) in Kidney Transplant Patients

Published: Sept 6, 2021 | Tags: Novartis, CIRRUS-1 Study, CFZ533, iscalimab, Kidney Transplant Patients

Related Post: PharmaShots Weekly Snapshots (August 30 – September 03, 2021)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post